毛梅,杨迥,吴高贤,傅祖红
MAO Mei 1; YANG Jiong 2; WU Gao-xian 1; FU Zu-hong 1 (1.Department of Pulmonary;

• 1:广州军区武汉总医院呼吸内科
• 2:武汉大学人民医院呼吸内科
• 3:广州军区武汉总医院呼吸内科
• 4:广州军区武汉总医院呼吸内科 湖北武汉430072

摘要(Abstract)：

目的 :探讨基质金属蛋白酶MMP 2在肺癌组织中的表达及与肺癌临床病理特征及预后的关系。方法 :用免疫组织化学的方法观察肺癌组织的MMP 2的表达。结果 :肺癌组织中MMP 2的表达显著高于正常肺组织 ,与临床分期、淋巴结转移有显著相关性。临床分期越高 ,MMP 2的表达越呈增加趋势 ,且随着MMP 2的表达增高而患者的生存期降低。结论 :MMP 2参与肺癌的侵袭和转移 ,是值得重视的生物学标志
Objective: To investigate the expression of MMP-2 in lung carcinoma and it’s relationship with clinical pathological characteristics and the prognosis of the disease. Methods: S-P immunohistological staining was used to detect the expression of MMP-2 in 58 cases of lung carcinoma and 58 cases of normal lung tissues. Results: The expression rates of MMP-2 were 63.8% and 31% in lung carcinoma tissue and normal lung tissue respectively. There was significant difference of expression between them, and the MMP-2 expression was closely correlated to lymph node metastasis and clinical stages. High carcinomatous MMP-2 values were of prognostic significance for poor survival of the patients. Conclusion: The expression of MMP-2 is closely correlated to lymph node metastasis and the clinical stages of lung carcinoma, and it might serve as a parameter for determining invasive and metastasis behavior of the tummor.

关键词(KeyWords)： 肺肿瘤;金属内肽酶类;免疫组织化学
lung neoplasms; metalloendopeptidases; immunohistochemistry

Abstract:

Keywords:

基金项目(Foundation):

作者(Authors): 毛梅,杨迥,吴高贤,傅祖红
MAO Mei 1; YANG Jiong 2; WU Gao-xian 1; FU Zu-hong 1 (1.Department of Pulmonary;

DOI: 10.19367/j.cnki.1000-2707.2004.03.006

参考文献(References)：

• [1]KleinerD ,StetlerStevensonW [J].CancerChemotherPhar maco,1999,43:42-51.
• [2]RiesC ,PetridesPE .Cytokineregulationofmatrixmetallopro teinasesactivityanditsregulatorydysfunctionindisease[J].BiologicalChemistryHoppeSeyler,1995,376(6):345-355.
• [3]GarbettEA ,ReedMW ,BrownNJ,etal.Proteolysisinhumanbreastandcolorectalcancer[J].BrJCancer,1999,81(2):287-293.
• [4]ThomasP ,KhokhaR ,ShepherdFA ,etal.Differentialexpres sionofmatrixmetalloproteinasesandtheirinhibitorsinnon smallcelllungcancer[J].J Pathol,2000,190(2):150-156.
• [5]DaviesB ,MilesDW ,HapperefieldLC ,etal.ActivityoftypeIVcollagenaseinbenignandmalignantbreastdisease[J].BrJCancer,1993,67(5):1126-1131.
• [6]FongKM ,KidaY ,ZimemermanPV ,etal.TIMP 1andadverseprognosisinnon smallcelllungcancer[J].ClinCancerRes,1996,2(8):1369.

文章评论(Comment)：